From: The global network antenatal corticosteroids trial: impact on stillbirth
RR (95 % CI)d | p-value | |||
---|---|---|---|---|
Characteristic a | Intervention | Control | ||
Babies, N | 48,698 | 52,007 | -- | -- |
Stillbirths (SB), N | 1,304 | 1,264 | -- | -- |
Male SB rate, N (Rate/1000) | 667 (26.6) | 672 (25.0) | 1.10 (0.99, 1.22) | 0.086d |
Female SB rate, N (Rate/1000) | 561 (23.8) | 540 (21.6) | 1.08 (0.96, 1.22) | 0.177d |
Birth weight percentile b, N (% of stillbirths) | 1,060 | 1,014 | 0.211e | |
< 5th | 601 (56.7) | 612 (60.4) | ||
5–24 | 161 (15.2) | 139 (13.7) | ||
25–49 | 110 (10.4) | 102 (10.1) | ||
50–74 | 83 (7.8) | 74 (7.3) | ||
75+ | 105 (9.9) | 87 (8.6) | ||
Birth weight categorizedc, N | 1,259 | 1,218 | ||
< 1000 g SB rate, N (Rate/1000) | 161 (631.4) | 197 (693.7) | 0.93 (0.83, 1.05) | 0.239d |
1000–1499 g SB rate, N (Rate/1000) | 272 (443.0) | 215 (378.5) | 1.22 (1.10, 1.36) | 0.0003d |
1500–2499 g SB rate, N (Rate/1000) | 360 (51.6) | 365 (57.4) | 0.91 (0.78, 1.06) | 0.218d |
2500+ g SB rate, N (Rate/1000) | 466 (11.4) | 441 (9.9) | 1.18 (1.04, 1.33) | 0.008d |
Preterm SB rate, N (Rate/1000) | 645 (116.6) | 681 (127.8) | 0.93 (0.83, 1.04) | 0.182d |
Term SB rate, N (Rate/1000) | 535 (12.8) | 477 (10.6) | 1.20 (1.06,1.37) | 0.004d |
Macerated, N (% of stillbirths) | 467 (35.8) | 385 (30.5) | 1.18 (1.04, 1.35) | 0.013f |
Women in the treatment group identified by the intervention as high risk who received steroids and delivered a stillborn baby | ||||
Time since 1st dose to delivery, N (%) | 271 | |||
Less Than 2 Days | 83 (30.6) | |||
2–7 Days | 53 (19.6) | |||
8–30 Days | 61 (22.5) | |||
More than one month | 74 (27.3) |